(HealthDay News) — A low risk of serotonin syndrome is seen in association with concomitant use of triptans and selective serotonin reuptake inhibitor (SSRI) or selective norepinephrine reuptake ...
Esketamine combined with a serotonin-norepinephrine reuptake inhibitor (SNRI) for treatment-resistant depression (TRD) was linked to significantly lower rates of several adverse outcomes than ...
A new study published in the Journal of Psychopharmacology found that serotonergic antidepressants like SSRIs and SNRIs can decrease psilocybin’s effects, Psychedelic Spotlight reports. Serotonergic ...
In a double-blind comparative study vs agomelatine, Brintellix met primary and secondary endpoints for efficacy and overall functioning in patients with major depression and inadequate response to ...
Among most ischemic (clot-caused) stroke survivors including those taking anticoagulant medications, use of antidepressants in the SSRI or SNRI class did not increase the risk of hemorrhagic (bleeds) ...
Among older patients with COPD, new use of serotonergic antidepressants was associated with small, but significant, increases in respiratory-related mortality, hospital admissions, and emergency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results